![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 18022 |
FusionGeneSummary for JAM3_SEC13 |
![]() |
Fusion gene information | Fusion gene name: JAM3_SEC13 | Fusion gene ID: 18022 | Hgene | Tgene | Gene symbol | JAM3 | SEC13 | Gene ID | 83700 | 6396 |
Gene name | junctional adhesion molecule 3 | SEC13 homolog, nuclear pore and COPII coat complex component | |
Synonyms | JAM-2|JAM-3|JAM-C|JAMC | D3S1231E|SEC13L1|SEC13R|npp-20 | |
Cytomap | 11q25 | 3p25.3 | |
Type of gene | protein-coding | protein-coding | |
Description | junctional adhesion molecule C | protein SEC13 homologGATOR complex protein SEC13SEC13 homolog, nuclear pore and COPII coating complex componentSEC13-like 1 isoformSEC13-like protein 1SEC13-related protein | |
Modification date | 20180519 | 20180523 | |
UniProtAcc | Q9BX67 | P55735 | |
Ensembl transtripts involved in fusion gene | ENST00000529443, ENST00000299106, ENST00000441717, ENST00000524969, | ENST00000397109, ENST00000337354, ENST00000350697, ENST00000397117, ENST00000383801, ENST00000492602, | |
Fusion gene scores | * DoF score | 4 X 4 X 3=48 | 8 X 5 X 4=160 |
# samples | 4 | 6 | |
** MAII score | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/160*10)=-1.41503749927884 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: JAM3 [Title/Abstract] AND SEC13 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | JAM3 | GO:0001525 | angiogenesis | 20592283 |
Hgene | JAM3 | GO:0090022 | regulation of neutrophil chemotaxis | 15194813 |
Tgene | SEC13 | GO:0090110 | cargo loading into COPII-coated vesicle | 17499046|18843296 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | LGG | TCGA-DU-7015-01A | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000529443 | ENST00000397109 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
Frame-shift | ENST00000529443 | ENST00000337354 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
Frame-shift | ENST00000529443 | ENST00000350697 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
Frame-shift | ENST00000529443 | ENST00000397117 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
Frame-shift | ENST00000529443 | ENST00000383801 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
5CDS-intron | ENST00000529443 | ENST00000492602 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
Frame-shift | ENST00000299106 | ENST00000397109 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
Frame-shift | ENST00000299106 | ENST00000337354 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
Frame-shift | ENST00000299106 | ENST00000350697 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
Frame-shift | ENST00000299106 | ENST00000397117 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
Frame-shift | ENST00000299106 | ENST00000383801 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
5CDS-intron | ENST00000299106 | ENST00000492602 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
Frame-shift | ENST00000441717 | ENST00000397109 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
Frame-shift | ENST00000441717 | ENST00000337354 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
Frame-shift | ENST00000441717 | ENST00000350697 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
Frame-shift | ENST00000441717 | ENST00000397117 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
Frame-shift | ENST00000441717 | ENST00000383801 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
5CDS-intron | ENST00000441717 | ENST00000492602 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
3UTR-3CDS | ENST00000524969 | ENST00000397109 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
3UTR-3CDS | ENST00000524969 | ENST00000337354 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
3UTR-3CDS | ENST00000524969 | ENST00000350697 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
3UTR-3CDS | ENST00000524969 | ENST00000397117 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
3UTR-3CDS | ENST00000524969 | ENST00000383801 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
3UTR-intron | ENST00000524969 | ENST00000492602 | JAM3 | chr11 | 134010665 | + | SEC13 | chr3 | 10347376 | - |
Top |
FusionProtFeatures for JAM3_SEC13 |
![]() |
Hgene | Tgene |
JAM3 | SEC13 |
Participates in cell-cell adhesion. It is a counter-receptor for ITGAM, mediating leukocyte-platelet interactions andis involved in the regulation of transepithelial migration ofpolymorphonuclear neutrophils (PMN). The soluble form is amediator of angiogenesis. {ECO:0000269|PubMed:12208882,ECO:0000269|PubMed:15194813, ECO:0000269|PubMed:20592283}. | Functions as a component of the nuclear pore complex(NPC) and the COPII coat. At the endoplasmic reticulum, SEC13 isinvolved in the biogenesis of COPII-coated vesicles.{ECO:0000269|PubMed:8972206}. As a component of the GATOR subcomplex GATOR2, functionswithin the amino acid-sensing branch of the TORC1 signalingpathway. Indirectly activates mTORC1 and the TORC1 signalingpathway through the inhibition of the GATOR1 subcomplex(PubMed:23723238). It is negatively regulated by the upstreamamino acid sensors SESN2 and CASTOR1 (PubMed:25457612,PubMed:27487210). {ECO:0000269|PubMed:23723238,ECO:0000269|PubMed:25457612, ECO:0000269|PubMed:27487210}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for JAM3_SEC13 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for JAM3_SEC13 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
JAM3 | PARD3, TJP1, ITGAM, JAM2, JAM3, RHOU | SEC13 | SEC16B, NUP37, NUP160, NUP133, NUP107, NUP85, SEC31A, RAB11A, SEC13, SIRT7, STAM2, CUL3, SEC23A, SLC12A2, RAD52, BAG3, CLDN12, MAPK9, EGFR, POLR2E, PRPF19, PSMB1, CSNK1A1, CSNK1E, FUS, TRAF5, RNF2, BCR, SPDL1, NUP98, SEH1L, MIOS, PRPF38A, WDR59, WDR24, STX7, ACY1, NUP43, MED4, TFG, QRICH1, SESN2, HSPB1, AHSA1, FLNB, NAPRT, SARS, SEC23B, SEPHS1, SEC24B, IFI16, EWSR1, B9D2, XPO1, CLTB, CLTC, FLNA, GAK, PICALM, AP1S2, SEC16A, GTSE1, MCM2, PPWD1, ZBTB5, CCDC94, FLYWCH2, WDR92, EDEM3, BRCA1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for JAM3_SEC13 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for JAM3_SEC13 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | JAM3 | C3151000 | HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS | 1 | CTD_human;ORPHANET;UNIPROT |